EichorEICHOR
Study identifier: NCT07029581 Synced from ClinicalTrials.gov · August 09, 2026
● Study status: Recruiting

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Condition: Lewy Body Dementia Psychosis  ·  Sponsor: ACADIA Pharmaceuticals Inc.

PhasePhase 2
Planned participants180
Who can joinAll sexes, 55 Years to 84 Years
Healthy volunteersNoCheck eligibility criteria ↓
Where59 locations · 6 countries

Interested? Contact the study team ↓

For sponsors, CROs & site teams
Professional view of this study — listed sites, countries and recruiting context from the public registry. Everything below is written for patients and caregivers.See where this study is running →

About this study

Multicenter, randomized, 6-week, double-blind, placebo-controlled, parallel-group, Phase 2 study in subjects with LBDP.

This description comes directly from the study's public registry record.

Talk to the study team

Kristin Kidd  ·  434-841-3162  ·  Kristin.kidd@acadia-pharm.com

Becky Howell  ·  848-702-1886  ·  bhowell@acadia-pharm.com

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Male or female ≥55 years to \<85 years of age at the Screening visit living in the community or, if permitted by local regulations, in an institutionalized setting * Can provide written informed consent. If the subject is deemed not competent to provide informed consent, the following requirements for consent must be met: 1. The subject's LAR must provide written informed consent. 2. The subject must provide written (if capable) informed assent per local regulations. * Meets either the clinical criteria for Parkinson's disease with dementia as defined by the Movement Disorder Society's Task Force or the revised clinical criteria for probable dementia with Lewy bodies (DLB) by consensus criteria (Fourth consensus report of the DLB Consortium). * Meets the revised criteria for psychosis in major or mild neurocognitive disorder established by the International Psychogeriatrics Association Exclusion Criteria: * Is in hospice, is receiving end-of-life palliative care, or is bedridden * Has psychotic symptoms that are primarily attributable to delirium, substance abuse, or a medical or psychiatric condition (e.g. schizophrenia, bipolar disorder, delusional disorder) other than dementia * Is actively suicidal at Visit 1 (Screening) or Visit 2 (Baseline) * Has a history or current evidence of a serious and/or significant unstable cardiovascular, respiratory, endocrine, gastrointestinal, renal, hepatic, hematologic, immunologic, genitourinary, psychiatric or neurologic (including stroke, chronic seizures, or clinically significant head injury) abnormality or disease or other medical disorder, including cancer or malignancies that could interfere with subject's ability to complete the study or comply with study procedures * Has other clinically significant CNS abnormalities that are most likely contributing to the dementia or findings on MRI or CT

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (59)

ATP Clinical Research Inc.Irvine, California, United StatesRecruiting
Georgetown UniversityWashington D.C., District of Columbia, United StatesRecruiting
Humanity Clinical Research, CorpAventura, Florida, United StatesRecruiting
Parkinson's Disease and Movement Disorders Center of Boca RatonBoca Raton, Florida, United StatesRecruiting
K2 Medical Research Winter Garden LLCClermont, Florida, United StatesRecruiting
University of Florida - ShandsGainesville, Florida, United StatesRecruiting
K2 Summit ResearchLady Lake, Florida, United StatesRecruiting
Neurology Associates, P. A.Maitland, Florida, United StatesRecruiting
Homestead Associates in Research IncMiami, Florida, United StatesRecruiting
Premier Clinical Research Institute, Inc.Miami, Florida, United StatesRecruiting
Advanced Clinical Research Network, CorpMiami, Florida, United StatesRecruiting
MediClear Medical & Research Center, Inc.Miami, Florida, United StatesRecruiting

+ 47 more locations — full list on the registry record.

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

IrvineWashington D.C.AventuraBoca Raton

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →